Patients who reach for acetaminophen or NSAIDs for pain relief now have a safe, fast-acting, natural option. A compound called Rhuleave-K combines the plant extracts of Boswellia and curcumin in a highly-absorbable, rapid onset form offering comparable analgesia to acetaminophen. In a randomized open label comparison trial with 1000 mg acetaminophen, 1000 mg of Rhuleave-K also provided noticeable relief in one hour, with complete pain relief achieved in three hours. See more on the technology along with the various clinical…

Urogenital recurrent infections affect millions of women because of the dramatic shifts in urogenital bacterial composition and concentrations. Even though most patients get improvement with antimicrobial treatment, the recurrence rate is high and associated with systemic side effects. Probiotics are healthy bacterial strains that not only improve the digestive system but also prevent and address urogenital infections and maintain vaginal health. The combination of Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14® probiotic strains has shown positive benefits in women with bacterial vaginosis (BV), urinary tract infections (UTI), and vulvovaginal…

Specific strains of lactobacilli and bifidobacterial have been shown to work together in combination in a number of clinical trials. This summary of clinical trials includes research on one or more of the strains Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus GG and HN001, Lactobacillus plantarum Lp-115, Lactobacillus paracasei Lpc-37, and Bifidobacterium lactis Bl-04, Bi-07 and HN019 as well as a trial using all eight. Finally, key mechanisms of action for each strain is summarized, from intestinal barrier support to intestinal nervous…

While a meta-analysis shows that probiotics reduce the duration of the common cold by an average of 1.89 days, Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 team up to reduce the duration of the common cold by as much as 2.4 days in one study. This research review covers mechanisms of action in multiple clinical trials as well as four double-blind randomized clinical trials on the common cold using 1 billion colony-forming units of this probiotic combination. Download the PDF

This document provides a summary of seven human clinical studies of a proprietary specialized pro-resolving mediators (SPM) formula. These studies involved different participants or patient types, including healthy volunteers, competitive athletes, and patients with chronic inflammatory conditions, fibromyalgia or chronic pain. Page 1 contains information of the study investigators and hyperlinks to additional educational materials. Pages 2-9 are excerpts from each study. Page 10 tabulates SPM dosage information from these studies in one table for easy viewing. Pages 11-13 provide…

In the following paper we present information from peer-reviewed publications to educate providers on how factors such as age, sex, sleep, and mood can affect responses to vaccines. We don’t have data on how these will affect the COVID-19 vaccine specifically, but this paper addresses how lifestyle and nutrients may be related to responses to other vaccines. Click to Download    

Specialized pro-resolving mediators (SPMs) are a group of lipid mediators that function as “resolution agonists” and actively coordinate the resolution of inflammation. Compared with healthy individuals, patients with many chronic inflammatory conditions have reduced levels of SPMs in circulation and in affected tissues. This suggests that resolution support is needed to bring this critical resolution system into balance. In this document, we compile clinical evidence demonstrating resolution deficit in several human conditions (Table 1). We also summarize the emerging preclinical…

Surgery is an inflammatory event. Several clinical conditions are associated with reduced levels of specialized pro-resolving mediators (SPMs), and many patients with these chronic conditions can be candidates for surgery and are at greater risks of reduced resolution capacity before going in for surgery. Further, circulating SPMs have been shown to drop immediately postsurgery, and higher levels of inflammation around the time of surgery has been associated with increased risk of complication and poorer outcomes. In this document, we describe…

Neuroinflammation is a driving factor in neurodegeneration and the adverse response to brain injury. For instance, individuals with Alzheimer’s disease have been shown to have reduced levels of specialized pro-resolving mediators (SPMs) in brain tissue, which are associated with cognitive function. In this document, we describe the scientific rationale for addressing inflammation for management of neurological conditions and summarize emerging preclinical animal and cell data highlighting impact of SPMs in neurodegenerative conditions as well as in cognitive and neurological response…

Endometriosis is a painful chronic inflammatory disorder impacting 10-15% of women of reproductive age. Endometrial lesions are major drivers of inflammation, leading to disruption of hormone regulation and immune function. In patients with endometriosis, the levels of specialized pro-resolving mediators (SPMs; specifically, LXA4) in their endometrial tissues are reduced. Given the link between endometriosis and chronic unresolved inflammation, assessing the impact of SPMs and pro-resolving therapies is a promising area of research. In this document, we describe the scientific rationale…